Swiss precision medicines company Haya Therapeutics completed a $65 million series A funding round. In connection with the deal, Kellerhals Carrard represented lead investors Sofinnova Partners and Earlybird Venture Capital, while Lenz & Staehelin assisted Eli Lilly, also amongst the investors participating to the round. Moreover, ATHOS, +ND Capital, Alexandria Venture Investments and LifeLink Ventures […]
Homburger advised Swiss cooperative bank Raiffeisen Schweiz Genossenschaft on its issuance of CHF 480 m in fixed rate senior bonds. The issuance Issued on May 14, 2025, the bonds encompass a first tranche of CHF 170 m at 0.85 per
Niederer Kraft Frey advised Swiss sports technology company Sportradar Group in connection with a USD 517.5 million underwritten secondary public offering by certain selling shareholders. The context Pursuant to the transaction, Sportradar Group implemented a conversion
Homburger advised the selling shareholders of Samaplast, a privately held Swiss company, on the sale of 100% of the company to a group of investors led by Philipp Looser. The company Samaplast is a specialist in
Bär & Karrer advised Sandberg Capital and ARX Equity Partners in connection with their acquisition of a majority stake in Travelnode, the holding company of Phobs, a software provider for the hospitality sector in
Lenz & Staehelin advised Swiss startup DeXentra on the launch of a public offering for up to USD 60 million of the OilXCoin, a debt instrument backed by DeXentra’s oil and gas assets and inventories,
Homburger advised 21Shares on the issuance and listing of its Dogecoin-linked Exchange Traded Product (DOGE) on the SIX Swiss Exchange. The context The issuance in question is linked to and fully physically collateralized by Dogecoin
Advestra advised Banque Cantonale de Genève on its inaugural EUR-Bonds of EUR 500 million. The issuance Banque Cantonale de Genève debuted on the EUR-bonds market, issuing bonds in the aggregate prin
Homburger advised New Zealand Local Government Funding Agency (LGFA) in connection with its debut issuance under its EMTN Programme, marking the the agency’s first issuance in CHF. UBS Investment Bank and BNP Paribas (Suisse) &
Advestra advised Galderma on its inaugural EUR 500 Million bonds as well as its dual tranche of CHF 435 million bonds. The context Galderma made its Euro Bond market debut with a EUR 500 million bonds
